Cerebral Oximetry Fails to Improve 2-Year Outcomes in Preterm Infants

Extremely preterm infants face a high risk of permanent neurologic impairment and mortality due to hemodynamic instability in the immediate postnatal period [1, 2]. To mitigate these risks, clinicians have increasingly utilized near-infrared spectroscopy, a noninvasive technology that provides real-time measurement of cerebral tissue oxygenation, to monitor brain perfusion [3]. Previous research established that using standardized treatment guidelines to respond to oximetry readings can successfully reduce the burden of cerebral hypoxia and hyperoxia [4, 3]. However, the clinical utility of targeting specific oxygenation ranges remains a subject of intense debate, as similar efforts to optimize systemic oxygen saturation have yielded conflicting results regarding long-term disability [5, 6]. A large-scale, multinational trial now provides definitive data on whether these early physiological interventions actually change neurodevelopmental trajectories at two years of age.